1887

Abstract

Poliovirus and enterovirus 71 (EV71) are both neurotropic enteroviruses that cause serious neurological diseases, such as poliomyelitis and encephalitis. The neurovirulence of EV71 in cynomolgus monkeys was demonstrated previously by intraspinal inoculation. In this study, an improved simian model of EV71 infection was established by using intravenous inoculation, which revealed clinical and neuropathological similarities between this model and human cases of encephalitis. Experimental EV71 infection induced direct neurological manifestations, such as tremor, ataxia and brain oedema, but not non-neurological complications, such as pulmonary oedema and cardiac failure. Using this model of EV71 infection, the neurotropic characteristics of the prototype strains of EV71 and poliovirus type 1 (PV1) were compared. Three monkeys were inoculated intravenously with 10 TCID EV71 and all developed neurological disease signs within 4–6 days of inoculation. However, after inoculation with 10 TCID PV1 strain OM1 (PV1-OM1), the major manifestation was flaccid paralysis, starting from the lower limbs 6–9 days post-inoculation. Histopathological and virological analyses of moribund monkeys revealed that disseminated EV71 infection was characterized by severe panencephalitis involving both the pyramidal and extrapyramidal systems. In contrast, the lesions induced by PV1-OM1 were mainly restricted to the pyramidal tract, particularly the spinal motor neurons, thalamus and motor cortex. In conclusion, neuropathological involvement in this model correlated well with the apparent differences in neurological disease induced by EV71 and PV1-OM1. Thus, intravenous inoculation with EV71 is an excellent model to study the neuropathology of EV71 and to evaluate candidate vaccines and potential antiviral agents.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.79883-0
2004-10-01
2024-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/10/vir852981.html?itemId=/content/journal/jgv/10.1099/vir.0.79883-0&mimeType=html&fmt=ahah

References

  1. Baker A. B. 1949; Bulbar poliomyelitis: its mechanism and treatment. Am J Med 6:614–619 [CrossRef]
    [Google Scholar]
  2. Bodian D., Howe H. A. 1940; An experimental study of the role of neurons in the dissemination of poliomyelitis virus in the nervous system. Brain 63:135–166 [CrossRef]
    [Google Scholar]
  3. Bodian D., Howe H. A. 1941; Experimental studies on intraneural spread of poliomyelitis virus. Bull Johns Hopkins Hosp 68:248–267
    [Google Scholar]
  4. Chan L. G., Parashar U. D., Lye M. S. 9 other authors 2000; Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis 31:678–683 [CrossRef]
    [Google Scholar]
  5. Chang L.-Y., Huang Y.-C., Lin T.-Y. 1998; Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet 352:367–368 [CrossRef]
    [Google Scholar]
  6. Chang L.-Y., Lin T.-Y., Hsu K.-H. 8 other authors 1999; Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682–1686 [CrossRef]
    [Google Scholar]
  7. Chumakov M., Voroshilova M., Shindarov L. 16 other authors 1979; Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 60:329–340 [CrossRef]
    [Google Scholar]
  8. Fujimoto T., Chikahira M., Yoshida S., Ebira H., Hasegawa A., Totsuka A., Nishio O. 2002; Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 46:621–627 [CrossRef]
    [Google Scholar]
  9. Hagiwara A., Tagaya I., Yoneyama T. 1978; Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9:60–63 [CrossRef]
    [Google Scholar]
  10. Hagiwara A., Yoneyama T., Hashimoto I. 1982; Isolation of a temperature-sensitive strain of enterovirus 71 with reduced neurovirulence for monkeys. J Gen Virol 64:499–502
    [Google Scholar]
  11. Ho M., Chen E.-R., Hsu K.-H., Twu S.-J., Chen K.-T., Tsai S.-F., Wang J.-R., Shih S.-R. 1999; An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 341:929–935 [CrossRef]
    [Google Scholar]
  12. Hovi T., Stenvik M. 1994; Selective isolation of poliovirus in recombinant murine cell line expressing the human poliovirus receptor gene. J Clin Microbiol 32:1366–1368
    [Google Scholar]
  13. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iizuka N., Takeuchi K., Takegami T., Nomoto A. 1990; The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 9:3217–3224
    [Google Scholar]
  14. Komatsu H., Shimizu Y., Takeuchi Y., Ishiko H., Takada H. 1999; Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr Neurol 20:17–23 [CrossRef]
    [Google Scholar]
  15. Liu C.-C., Tseng H.-W., Wang S.-M., Wang J.-R., Su I.-J. 2000; An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol 17:23–30 [CrossRef]
    [Google Scholar]
  16. Lum L. C. S., Wong K. T., Lam S. K. 7 other authors 1998; Fatal enterovirus 71 encephalomyelitis. J Pediatr 133:795–798 [CrossRef]
    [Google Scholar]
  17. McMinn P., Stratov I., Nagarajan L., Davis S. 2001; Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32:236–242 [CrossRef]
    [Google Scholar]
  18. Melnick J. L. 1984; Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis 6:S387–S390 [CrossRef]
    [Google Scholar]
  19. Mendelsohn C. L., Wimmer E., Racaniello V. R. 1989; Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855–865 [CrossRef]
    [Google Scholar]
  20. Nadkarni S. S., Deshpande J. M. 2003; Recombinant murine L20B cell line supports multiplication of group A coxsackieviruses. J Med Virol 70:81–85 [CrossRef]
    [Google Scholar]
  21. Nagata N., Iwasaki T., Ami Y. 7 other authors 2001; Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys. Vaccine 19:3201–3208 [CrossRef]
    [Google Scholar]
  22. Nagata N., Shimizu H., Ami Y. 7 other authors 2002; Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol 67:207–216 [CrossRef]
    [Google Scholar]
  23. Oberste M. S., Maher K., Kilpatrick D. R., Pallansch M. A. 1999; Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73:1941–1948
    [Google Scholar]
  24. Pipkin P. A., Wood D. J., Racaniello V. R., Minor P. D. 1993; Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J Virol Methods 41:333–340 [CrossRef]
    [Google Scholar]
  25. Ponnuraj E. M., John T. J., Levin M. J., Simoes E. A. F. 1998; Cell-to-cell spread of poliovirus in the spinal cord of bonnet monkeys ( Macaca radiata ). J Gen Virol 79:2393–2403
    [Google Scholar]
  26. Pulli T., Koskimies P., Hyypiä T. 1995; Molecular comparison of coxsackie A virus serotypes. Virology 212:30–38 [CrossRef]
    [Google Scholar]
  27. Schmidt N. J., Lennette E. H., Ho H. H. 1974; An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 129:304–309 [CrossRef]
    [Google Scholar]
  28. Shiroki K., Ishii T., Aoki T., Kobashi M., Ohka S., Nomoto A. 1995; A new cis -acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J Virol 69:6825–6832
    [Google Scholar]
  29. Wang J.-R., Tuan Y.-C., Tsai H.-P., Yan J.-J., Liu C.-C., Su I.-J. 2002; Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol 40:10–15 [CrossRef]
    [Google Scholar]
  30. WHO 1990; Requirements for poliomyelitis vaccine (oral). WHO Tech Rep Ser 800:30–65
    [Google Scholar]
  31. WHO 2002; The Global Poliomyelitis Eradication Initiative: number of endemic countries at lowest ever. Wkly Epidemiol Rec 77:414–415
    [Google Scholar]
  32. Wong K. T. 2000; Emerging and re-emerging epidemic encephalitis: a tale of two viruses. Neuropathol Appl Neurobiol 26:313–318 [CrossRef]
    [Google Scholar]
  33. Wong K. T., Chua K. B., Lam S. K. 1999; Immunohistochemical detection of infected neurons as a rapid diagnosis of enterovirus 71 encephalomyelitis. Ann Neurol 45:271–272 [CrossRef]
    [Google Scholar]
  34. Wood D. J., Hull B. 1999; L20B cells simplify culture of polioviruses from clinical samples. J Med Virol 58:188–192 [CrossRef]
    [Google Scholar]
/content/journal/jgv/10.1099/vir.0.79883-0
Loading
/content/journal/jgv/10.1099/vir.0.79883-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error